IQInvest research note
25 AUG 2026 · 16:23 ET
MRK
Merck & Co., Inc.
$154.02
$3.36 (+2.23%)up 2.23%
25 August 2026 · delayed 15+ min
D
Cut-offs are the grader's own: 97+ for an A+, below 60 is an F.
Merck & Co., Inc. earns a D on positive free cash flow and price well above 200-day SMA (strong uptrend) but high debt-to-equity ratio (>2.0) and RSI overbought (>70). Consider alternatives with better risk/reward profiles.
Adjusted for Moderate investors, Medium-term investors 4.0% suggested allocation Change these
IQ-MRK-20260825engine v1 · 7-category weighted scorecard